Our findings of upregulated VEGFA levels in ADPKD and CKD are in support of these results and might be of special interest, as there are VEGF-, VEGF receptor- but also HIF-1α-antagonists discussed as therapeutic options [42,43]. Here, HIF1A is linked to autosomal dominant polycystic kidney disease.